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Abstract 
Aims 
Linalool is a plant-derived monoterpene with anticancer activity, however its mechanisms 
of action remain poorly understood. The aim of this work was to elucidate the anticancer 
mechanisms of action of linalool in hepatocellular carcinoma (HCC) HepG2 cells.  
Main methods 
Cell viability and proliferation were determined by WST-1 assay and BrdU incorporation, 
respectively. Cell cycle analysis was assessed through flow cytometry (FC) and western 
blot (WB). Apoptosis was determined by caspase-3 activity, TUNEL assay and WB. 
Reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were 
analyzed by FC and fluorescence microscopy. Expression of Ras, MAPKs (ERK, JNK and 
p38) and Akt/mTOR pathways were evaluated by WB. 
Key findings 
Linalool (0-2.5 mM) dose-dependently inhibited cell proliferation by inducing G0/G1 cell 
cycle arrest, through Cdk4 and cyclin A downregulation, p21 and p27 upregulation, and 
apoptosis, characterized by MMP loss, caspase-3 activation, PARP cleavage and DNA 
fragmentation. Low concentrations of linalool (1.0 mM) reduced membrane-bound Ras and 
Akt activity whereas higher amounts (2.0 mM) triggered mTOR inhibition and ROS 
generation, in correlation with MAPKs activation and Akt phosphorylation. ROS scavenger 
N-acetyl-L-cysteine partially rescued HepG2 cell growth and prevented MPP 
depolarization, ERK and JNK activation. Moreover, specific ERK and Akt phosphorylation 
inhibitors potentiated linalool anti-cancer activity, pointing Akt and ERK activation as pro-
survival mechanisms in response to higher concentrations of linalool.  
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Significance 
This report reveals that linalool induces G0/G1 arrest and apoptosis in HepG2 cells 
involving Ras, MAPKs and Akt/mTOR pathways and suggests that linalool is a promising 
anticancer agent for HCC therapy. 
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1. Introduction 
Hepatocellular carcinoma (HCC) is the fifth most frequent cancer worldwide, and the third 
cause of cancer mortality. Most of actual therapies including surgery, tumor ablation, liver 
transplantation and chemotherapy are limited to only about 30% of patients, with 
recurrence rates being very high. For these reasons, HCC 5 years survival after diagnosis 
reaches less than 5% [1]. In this context, new therapies targeting specific signaling 
pathways involved in HCC emerge as a promising new tool for HCC treatment. 
Phytochemicals arise as potential alternative or supplementary anti-cancer agents mainly 
due their high effectiveness and low systemic toxicity [2, 3]. Monoterpenes are naturally 
occurring isoprenoids commonly found in essential oils of citrus fruits and aromatic plants 
with anticancer properties both in vitro and in vivo [4,5]. Pioneer reports proposed that 
monoterpenes acted through inhibition of Ras prenylation, which is essential for its cell 
membrane anchorage-dependent activity [6,7]. Ras GTPase plays a central role in 
promoting cell proliferation and survival through its downstream signaling Raf/MEK/ERK 
and PI3K/Akt/mTOR pathways. Oncogenic Ras exerts its transforming activity in 
hepatocarcinogenesis mainly by promoting an uncontrolled proliferative signaling mediated 
by both pathways [8]. For these reasons, several agents capable of blocking Ras and 
downstream signaling pathways are under evaluation for HCC treatment [9,10]. 
On the other hand, some phytochemicals could exert their antitumor effect by inducing 
cellular insults in tumor cells (RE stress, oxidative stress) therefore promoting the 
activation of stress response pathways including MAPKs (mitogen-activated protein 
kinases). MAPKs comprise the extracellular signal-related kinases (ERKs), and the stress-
activated p38 kinases and c-jun NH2-terminal kinases (JNKs) [11]. Reactive oxygen 
species (ROS) appear as one of the main mechanisms by which most of anticancer drugs 
exert their antineoplasic effects, particularly through the activation of MAPKs and the 
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promotion of mitochondrial membrane depolarization, leading to cell growth arrest, 
apoptosis, senescence and/or autophagy [12-15].  
Linalool (3,7-dimethyl-1,6-octadien-3-ol) is a linear monoterpene alcohol present in 
essential oils of more than 200 species of plants and herbs like coriander (74.2%), basil 
(63%), oregano (38%) and grapevine (27.3%), among others [16]. The pharmacological 
activities of this 10-carbon isoprenoid were evaluated both in vitro and in vivo and were 
found having sedative, analgesic, anti-inflammatory, antioxidant, antimicrobial, and 
antitumor properties among others [17,18]. Linalool was reported to induce cell cycle 
arrest and/or apoptosis in a wide variety of human cancer cells such as prostate [19], 
leukemia [20,21], cervical [21], breast [22], sarcoma [23] and epithelial ovarian cancer cells 
[24], however no reports for HCC cells are available to this respect and the mechanisms 
by which these effects are produced are not completely understood. We have previously 
shown the ability of linalool to inhibit the mevalonate pathway and cell growth in HepG2 
and A549 cells [25], suggesting that its anticancer activity could be due to the inhibition of 
Ras prenylation, which is essential to promote tumorigenesis [26].  
The purpose of the present study was to examine the molecular mechanisms involved in 
the antiproliferative activity of linalool in HepG2 hepatocellular carcinoma cells with 
particular interest in the role of Ras, MAPKs and Akt/mTOR signaling pathways. 
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2. Materials and Methods 
2.1. Chemicals 
Linalool>95%, N-acetyl-L-cysteine (NAC), Propidium Iodide (PI), rhodamine-123 (Rh-123), 
U0126, Ly294002, 2,7-dichlorodihydroﬂuorescein diacetate (DCFH-DA), apocynin, 
lipopolysaccharide (LPS) and dimethylsulfoxyde (DMSO) were purchased from Sigma 
Chemical Co. (St Louis, MO, USA). Dulbecco's Minimal Essential Medium (DMEM), fetal 
bovine serum (FBS), penicillin-streptomycin (P/S) and non-essential amino acids (NEAA) 
were obtained from Gibco (Invitrogen Corporation, USA). Protease and phosphatase 
inhibitor cocktails (cat. 88666 and 78420) were from Thermo Scientific (Rockford, USA). 
Anti-pan-Ras, anti-phospho-ERK (Thr202/Tyr204), anti-phospho-Akt (Ser473), anti-
phospho-p38 (Thr180/Tyr182), anti-p38, anti-phospho-JNK (Thr183/Tyr185), anti-
phospho-p70S6K (Thr389), and anti-PARP antibodies were from Cell Signaling 
Technology (Danvers, MA, USA). Anti-p70S6K, anti-Cdk2, anti-Cdk4, anti-cyclin A, anti-
cyclin D1, anti-cyclin E, anti-p21, anti-p27, anti-p53 antibodies were from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). Anti-ERK and anti-Akt antibodies were from BD 
Biosciences. Anti-β-actin antibody was from Sigma Aldrich (Bornem, Belgium).  
 
2.2. Cell culture and treatments 
The human hepatocarcinoma cell line HepG2 (HB-8065) was purchased from the 
American Type Culture Collection. The cells were cultured in T-75 tissue culture flasks in 
DMEM supplemented with 10% FBS (v/v) plus 1% P/S, 1% NEAA, in 5% CO2 at 37°C. 
The medium was changed every 2 days and the cells were passaged when they reached 
80% confluence. For experiments, cells were grown under standard conditions and 
allowed to adhere overnight. Thereafter, they were incubated in DMEM supplemented with 
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0.1% DMSO (vehicle) or linalool at different concentrations for up to 72 h. The medium 
was replaced every 24 h. To study the role of ROS in different cellular processes, HepG2 
cells were pre-treated with NAC 5 mM or apocynin 250 µM 2 h prior to co-treatment with 
linalool.  
 
2.3. Cell viability  
HepG2 cells seeded in 96-well plates at a density of 5 × 103 cells per well were incubated 
in medium supplemented with DMSO 0.1 % or linalool (0-2.5 mM). Cell viability was 
determined using a colorimetric WST-1 assay (Roche, Vilvoorde, Belgium) according to 
the manufacturer´s instructions.  
 
2.4. Determination of DNA synthesis 
DNA synthesis was determined using a colorimetric immunoassay based on 
bromodeoxyuridine (BrdU) incorporation into the cellular DNA, according to the 
recommendations of the manufacturer (Roche). The experimental design was identical to 
the experiments set for the WST-1 assay. DNA synthesis was assessed after 24, 48 and 
72 h of treatment and BrdU was added for the last 4 h of the experiment.  
 
2.5. Cell cycle analysis 
Cells were plated in 6 well plates at a density of 3 × 105 and allowed to adhere overnight 
(ON). After treatments, the cells were harvested by trypsinization, centrifuged at 500 x g 
for 5 min, resuspended in PBS and fixed in 70% ice-cold ethanol for 4 h at 4°C. Then, cells 
were washed twice with PBS and treated with RNase A (0.1 mg/ml, Sigma Aldrich) for 30 
min at 37°C. Finally, cells were stained with DNA staining solution (0.025 mg/ml PI, 0.1% 
(v/v) Triton X-100) in the dark for 30 min. The stained cells were detected by flow 
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cytometry using a FACSAriaII flow cytometer (Becton Dickinson, California, USA) and data 
analyzed by Flow Jo 7.6.2 (Tree Star, Oregon, USA).  
 
2.6. Measurement of caspase-3 activity 
Caspase-3 activity was determined using a colorimetric Caspase-3 Assay Kit (Sigma, St. 
Louis, MO, USA) according to the manufacturer’s instructions.  
 
2.7. TUNEL Assay 
Apoptotic DNA fragmentation was assessed using a TUNEL assay (In-Situ Cell Death 
Detection Kit, TMR Red, Roche, Mannheim, Germany). HepG2 cells were plated on sterile 
coverslips (24x24 mm) in 6 well plates at a density of 3 × 105 and allowed to attach 
overnight. After treatment with linalool (1.0-2.0 mM) for 24 and 48 h, cells were washed 
three times with PBS and then fixed with 4% paraformaldehyde in PBS for 60 min at room 
temperature. The cells were then washed twice and permeabilized with 0.1% Triton X-100 
(v/v) in PBS for 2 min on ice followed by TUNEL reaction mixture for 1 h at 37°C in the 
dark. After the reaction, the slides were mounted with ProLong® Gold Antifade Reagent 
with DAPI (4′,6-diamidino-2-phenylindole dihydrochloride) for nuclear staining (Life 
Technologies, Carlsbad, CA) and examined under an Olympus BX51 Fluorescence 
Microscope (Tokyo, Japan) equipped with an Olympus DP70 digital camera. Images were 
analyzed using ImagePro Plus v. 5.1 software (Media Cybernetics, Silver Spring, MD). 
 
2.8. Measurement of intracellular ROS 
Intracellular ROS production was quantified using the peroxide-sensitive ﬂuorescent probe 
DCFH-DA (Sigma Aldrich). HepG2 cells were seeded in 6-well plates (3 × 105) and treated 
for 3h with DMSO 0.1 % (Control), linalool (1.0, 1.5 and 2.0 mM), hydrogen peroxide 0.4 
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mM (positive control), or pretreated with NAC 5 mM 2 h prior to addition of linalool 1.5 mM. 
Then, cells were stained in serum-free DMEM containing 10 µM DCFH-DA in the dark for 
30 min at 37 °C. Thereafter, cells were harvested, washed twice with PBS, resuspended in 
1 ml PBS and immediately examined by flow cytometry using a FACSCantoII flow 
cytometer (Becton Dickinson, California, USA) with an excitation wavelength of 488 nm 
and emission wavelength of 525 nm. Data were analyzed by Flow Jo 7.6.2 (Tree Star, 
Oregon, USA). In a parallel experiment, after treatment of HepG2 cells seeded in 24-well 
plates (5 × 104), cells were washed twice with PBS and exposed to 10 µM DCFH-DA in the 
dark for 30 min at 37 °C. After washed twice with PBS, cells were imaged under an 
Olympus LX71 Inverted Fluorescence Microscope (Tokyo, Japan) equipped with an 
Olympus digital camera (E-330). 
 
2.9. Measurement of Mitochondrial Membrane Potential (MMP) 
MMP was determined using fluorescent dye Rh-123, a membrane-permeable cationic 
ﬂuorescent dye which accumulates in mitochondria as a direct function of the membrane 
potential. HepG2 cells were treated with linalool 1.5 mM for 3, 24 and 48 h and then 
collected and washed twice with PBS. The cell suspension was stained with 5 μM Rh-123 
for 30 min at 37°C in the dark, centrifuged at 500 x g for 7 min, washed twice with PBS 
and resuspended in 1 ml PBS. The fluorescence intensity was measured immediately by 
FACSCantoII flow cytometer with an excitation wavelength of 488 nm and emission 
wavelength of 525 nm. In addition, HepG2 cells seeded in 24-well plates (5 × 104) were 
incubated with linalool 1.5 mM for 3, 24 and 48 h, linalool 1.0 to 2.0 mM for 24h, or 
rotenone 5 µM for 12 h as a positive control. After washed three times with PBS, cells 
were stained with 10 μM Rh-123 in free-serum DMEM for 30 min at 37°C in the dark, again 
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washed three times with PBS and imaged under an Olympus LX71 Inverted Fluorescence 
Microscope (Tokyo, Japan) equipped with an Olympus digital camera (E-330).  
 
2.10. Western Blot analysis 
Cells were plated in 100 mm Petri dishes at a density of 2 × 106 and allowed to adhere 
ON. After treated with linalool 1.0 to 2.0 mM for 24-48 h, cells were washed twice in PBS 
and lysed in RIPA buffer [(50 mM Tris-HCl–pH 8.0, 150 mM NaCl, 1.0 % (v/v) NP-40, 0.5% 
(w/v) sodium deoxycholate, 0.1% SDS, and 1 mM EDTA)] containing protease and 
phosphatase inhibitors for 30 minutes on ice and centrifuged 15 min at 14,000 x g at 4°C. 
The concentration of total proteins was measured BCA protein assay (Pierce, Rockford, 
IL). Equal amounts of protein (30-60 μg) were resolved on a 10-12% SDS-PAGE and 
transferred onto a polyvinylidene ﬂuoride membranes (PVDF, Amersham, GE Healthcare). 
Membranes were blocked for 60 min in 5% bovine serum albumin (BSA) in TBST buffer 
(150 mM NaCl, 10 mM Tris-HCl– pH 7.4, 0.05% Tween-20) at room temperature and 
incubated with primary antibodies at a dilution of 1:200 to 1:1000 at 4 °C, overnight. 
Immunoreactivity was detected by using horseradish peroxidase-conjugated anti-rabbit or 
anti-mouse IgG and visualized with the Western Lightning Chemiluminescent Reagent 
Plus (Perkin Elmer, Boston, MA) by the Gel Doc TMXR System 170–8170 device and 
software (Bio-Rad, Nazareth, Belgium). β-actin was used as loading control. 
 
2.11. Ras subcellular localization 
The different subcellular fractions were obtained using a protocol adapted from Palozza et 
al.[27]. Briefly, cells were washed twice with PBS and lysed in lysis buffer (10 mM Tris-
HCl–pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0,5% TritonX-100) supplemented with protease 
inhibitors for 15 min on ice. Thereafter, cells were collected and homogenized by 20 
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passes through a 27 ga needle on ice. The homogenate was further centrifuged for 10 min 
at 500 x g to obtain the postnuclear fraction, which was ultracentrifuged at 100,000 x g for 
60 min (Beckman Optima LE-80K, SW60Ti rotor) to obtain a pellet of the cell membrane 
fraction, and the cytosol fraction in the supernatant. The pellet was suspended in 
membrane resuspension buffer [10 mM Tris-HCl–pH7.4, 100 mM NaCl, 1 mM EDTA, 1 
mM EGTA, 1% TritonX-100, 0,1% SDS] supplemented with protease inhibitors. Protein 
samples from membrane (100 μg), cytosol and homogenate (20 μg each one) were 
subjected to Western Blot analysis as described earlier (section 2.10). 
 
2.12. Statistics  
Results are expressed as relative change compared with DMSO controls and presented 
as means ± SD. Statistical significance was determined using the Student t-test. 
Significance was set at p< 0.05 (GraphPad inStat program). 
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3. Results 
3.1. Linalool suppressed HepG2 cells proliferation and growth  
To investigate linalool-induced growth inhibition, we performed a WST-1 assay to analyze 
HepG2 cell viability. Significant cell viability inhibition was observed for concentrations 
from 1.0 mM after 24-48 h, and from 0.5 mM after 72 h, then cell viability decreased in a 
dose- and time- dependent manner (Fig. 1A). Given that WST-1 assay evaluates healthy 
cells but does not distinguish between quiescent or actively dividing cells, we also used 
the BrdU incorporation assay to measure specific cell proliferation rate. Linalool impaired 
DNA synthesis in HepG2 cells in a significant dose-dependent manner already at 0.5 mM 
at 24 h and at 0.25 mM after 48-72 h (Fig. 1B). These results suggest that linalool acts as 
an antiproliferative drug at concentrations were cell viability is not altered.  
 
Fig. 1. Linalool inhibited HepG2 cell viability and proliferation. Cells were plated in 96-wells 
plates and incubated with various concentrations of linalool (0-2.5 mM) for 24, 48 and 72 h. (A) Cell 
viability assessed by WST-1 expression showing a dose- and time-dependent decrease in HepG2 
cell viability. (B) BrdU incorporation into DNA showing a dose-dependent inhibition of HepG2 cell 
proliferation exerted by linalool. Data are presented as the mean ± SD (n=8). *p<0.05; 
**p<0.01;***p<0.001. 
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3.2. Linalool promoted G0/G1 phase cell cycle arrest  
In order to determine the potential mechanisms by which linalool impairs HepG2 cell 
proliferation, cell cycle progression was analyzed by flow cytometry (Fig. 2A,B). As shown 
in Fig. 2A, after 24 h exposure of HepG2 cells to 1.0mM linalool, a significant G0/G1 phase 
arrest was observed which further increases with 2.0mM of linalool. In parallel, a 
concomitant decrease of cells in S phase from 20.7% in control cells to 6.2% for 2.0 mM 
linalool (p<0.001) occurred whereas no significant differences were found in the G2/M 
population. Similar results were observed for 48 h of treatment, with however a higher 
percentage of cells arrested in G0/G1 (79.2%) after incubation with linalool 1.0 mM with 
respect to 24 h treatment (p<0.05, Fig. 2B). 
To get some insight into the molecular mechanisms of linalool-induced G0/G1 arrest, 
expression of cyclins A, D1 and E, Cdk2, Cdk4, p21, p27 and p53 were analyzed by 
Western Blotting after 24 h treatments (Fig. 2C,D). Although, linalool induced no significant 
changes in Cdk2 and cyclin D1 levels, a dose-dependent down-regulation in the 
expression of Cdk4 and cyclin A up to 53 and 45%, respectively (p<0.05) was observed. 
Moreover, a slightly but significant 17% decrease in cyclin E levels was also found in 
HepG2 cells incubated with linalool 2.0 mM (Fig. 2D). Expression of both p21 and p27, 
negative regulators of G1 progression, strongly increased after 1.0 and 1.5 mM linalool 
treatments (1.4-1.8 folds, p<0.05), but not in cells exposed to linalool 2.0 mM with respect 
to control cells. p53 levels notably diminished in HepG2 cells in response to linalool 
treatments starting from 1.5 mM onwards (p<0.05).  
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Fig. 2. Linalool induced G0/G1 cell cycle arrest. (A-B) Cell cycle distribution in HepG2 cells after 
exposed to linalool for 24 h (A) and 48 h (B). Data are expressed as mean ± SD (n=4). (C) HepG2 
cells were incubated with increasing concentrations of linalool for 24 h. Representative immunoblots 
of cyclin A, cyclin D1, cyclin E, Cdk2, Cdk4, p21, p27, p53 and β-actin (loading control). (D) 
Quantification of protein levels by densitometric analysis (n=4). Data are expressed as the mean ± 
SD. *p<0.05; **p<0.01;***p<0.001  
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3.3. Linalool induced apoptosis in HepG2 cells 
We next assessed the ability of linalool to induce apoptosis in HepG2 cells. We first 
assayed caspase-3 activity, an effector caspase which is activated upon initiation of both 
the intrinsic and extrinsic apoptotic pathways. No caspase-3 activation was detected after 
24 h treatments in response to any of the concentrations tested (1.0-2.0 mM) whereas a 
significant 2.2 to 2.4-fold induction was observed after exposition to linalool 1.5 and 2.0 
mM for 48 h (Fig. 3A). Another hallmark for apoptotic cell death is the DNA fragmentation 
produced by caspase-activated endonucleases. Therefore, DNA breaks in cells were 
analyzed by means of the TUNEL assay (Fig. 3B). No significant differences were found 
after 24 h linalool treatments respect to control cells (data not shown) whereas TUNEL-
positive apoptotic nuclei increased from 0.32% to 5.77% and 10.04% in HepG2 cells 
treated for 48 h with linalool 1.5 and 2.0 mM, respectively (Fig. 3C, p<0.001). Furthermore, 
a third line of evidence for linalool-induced apoptosis was obtained through the analysis of 
the apoptotic marker PARP, which is cleaved after caspase-3 activation. A significant 
dose-dependent decrease in the PARP levels in parallel with the increase of the cleavage 
product was detected after 48 h linalool treatment (Fig. 3D). Altogether, these results 
demonstrates that linalool is able to induce apoptosis in HepG2 cells after 48 h treatments 
at concentrations starting from 1.5 mM.  
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Fig. 3. Linalool induced apoptosis in HepG2 cells. HepG2 cells were treated with linalool (1.0, 
1.5 and 2.0 mM) for 24 and 48 h and apoptosis was determined by different methodologies. (A) 
Caspase-3 activity was determined colorimetrically and the results were normalize to control cells 
(AU= arbitrary units, n=4). Data are presented as the mean ± SD; *p<0.05; **p<0.01;***p<0.001. (B) 
Representative fluorescence micrographs of apoptotic cells labeled by TUNEL assay after 48 h 
treatments with DMSO 0.1 % (Control) or linalool (LN) at the mentioned concentrations. Cells were 
examined under an Olympus BX51 fluorescence microscope (magnification × 10). Upper panel, 
nuclei stained with DAPI; lower panel, red-stained TUNEL positive cells. (C) Quantification of 
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TUNEL positive cells. About 10-15 fields (100-200 cells/field) of three independent experiments 
were evaluated. Data are expressed as the mean ± SD. *p<0.05; **p<0.01;***p<0.001. (D) 
Representative immunoblot showing the poly ADP ribose polymerase (PARP) cleavage (apoptotic 
marker) after 48 h treatment (n=4).  
 
3.4. Linalool effects on Ras expression 
We next measured the levels of Ras on the cell membrane and in cytosolic fractions after 
exposing HepG2 cells to linalool 1.0, 1.5 and 2.0 mM for 24 and 48 h (Fig. 4A-B). After 24 
h, Ras membrane expression decreased about 30-35% for all tested concentrations 
(p<0.001) without significant changes in cytosolic Ras levels (Fig. 4C). The effect was 
even more pronounced after 48 h, where membrane Ras strongly decreased up to 50% 
(p<0.001). In parallel, a modest increase of 16% and 25% (p<0.05) in cytosolic Ras and 
total Ras, respectively, was observed upon treatment with linalool 1.5 mM (Fig. 4D).   
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Fig. 4. Effect of linalool on Ras expression. HepG2 cells were treated with linalool (1.0, 1.5 and 
2.0 mM) for 24 and 48 h. (A-B) Representative Western Blots of Ras protein in the membrane 
(mem-Ras) and cytosolic (cyt-Ras) fractions and total Ras after 24 h (A) and 48 h (B) treatments. 
(C-D) The resulting bands for 24 h (C) and 48 h (D) treatments were quantified by densitometric 
analysis and then normalized to their respective β-actin. Data are expressed as relative change 
compared to the control group, arbitrarily set at 1 and expressed as the mean ± SD of two 
independent experiments performed by quadruplicate. *p<0.05; **p<0.01;***p<0.001.  
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3.5. Linalool induced ROS production 
We next evaluated whether linalool was able to induce ROS generation by flow cytometry 
and fluorescence microscopy (Fig. 5A). Linalool substantially induced ROS generation at 
1.5 and 2.0 mM (Fig. 5A, lower panel). In addition, flow cytometry analysis also showed 
that linalool significantly increased ROS levels at 1.5 mM (3.2 folds) and 2.0 mM (6.8 folds) 
and pre-treatment with the antioxidant NAC was able to prevent such an increase (Fig. 
5B). To get some insight into the source of ROS generation, the effect of apocynin (a 
specific NADPH oxidase inhibitor) on linalool-induced ROS production was analyzed under 
fluorescence microscopy. As shown in figure 5C, apocynin did not prevent linalool-induced 
ROS production.  
In order to analyze the involvement of ROS in linalool-induced cell growth inhibition, 
HepG2 cells were treated with linalool in absence or presence of 5 mM NAC or 250 µM 
apocynin. After 24 h treatments with linalool 1.5 and 2.0 mM, NAC was able to restore cell 
viability from 73.5 and 55.3% to 83.8 and 80.2% respectively. However, after 48 and 72 h, 
this ROS scavenger molecule could only partially rescue cell growth. On the other hand, 
apocynin was unable to prevent cell viability loss induced by linalool at any of the tested 
conditions (Fig. 5D).  
These results suggest that ROS production, at least in part, contributes to the 
antiproliferative effects exerted by linalool. 
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Fig. 5. Oxidative stress induced by linalool. (A-B) HepG2 cells were treated with DMSO 0.1 % 
(Control), linalool (LN, 1.0, 1.5 and 2.0 mM) or pretreated with NAC 5 mM 2 h prior to addition of 
linalool 1.5 mM (LN 1.5 mM + NAC) for 3h, and then stained with 10 μM DCFH-DA for 30 min. (A) 
ROS production was evaluated by flow cytometry (upper panel). Representative images of HepG2 
cells showing ROS positive cells under a fluorescence microscope (20X, lower panel). (B) The 
fluorescence intensity of the cells analyzed by flow cytometry was calculated relative to that of 
control (set at 1). Data are expressed as the means ± SD of three independent experiments (n=4). 
*p<0.05; **p<0.01;***p<0.001. (C) HepG2 cells were treated with DMSO 0.1 % (Control), LPS (1 
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µg/ml) or pretreated with apocynin (Apo, 250 µM) 2 h prior to addition of LPS (LPS + Apo) or LN 1.5 
mM (LN + Apo), and intracellular ROS were detected under a fluorescence microscope (20X). (D) 
HepG2 cells were pre-incubated with the ROS scavenger NAC (5 mM) or apocynin (250µM) 2 h 
prior to the addition of linalool (1.0 – 2.0 mM) for 24, 48 and 72 h. Cell viability was assessed by 
WST-1 expression. Data are presented as mean ± SD (n=8). *p<0.05; **p<0.01;***p<0.001. 
 
3.6. Linalool decreased Mitochondrial Membrane Potential (MMP) 
MMP collapse is a sign of ROS-induced mitochondrial damage and a major stimulus for 
apoptosis. Linalool 1.5 mM produced a time-dependent loss in MMP after 24 h (p<0.05) 
and 48 h (p<0.01) of treatment, as evidenced by flow cytometry (Fig. 6A). To further 
confirm these findings, HepG2 cells were exposed to linalool in time-course and dose-
dependent manner and MMP evaluated under fluorescence microscopy (Fig. 6). A time- 
and dose-dependent decrease in rh-123 content in HepG2 cells (green fluorescence) was 
observed, supporting the ability of linalool to alter mitochondrial integrity. Furthermore, 
NAC prevented cell depolarization, as shown by a greater green fluorescence intensity in 
HepG2 cells pre-treated with the antioxidant agent before addition of linalool 1.5 mM for 48 
h (Fig. 6B, right upper panel). 
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Fig. 6. Effect of linalool on mitochondrial membrane potential (MMP) in HepG2 cells. (A) 
HepG2 cells were treated with DMSO 0.1 % (Control) or linalool 1.5 mM at different time points (0-
48 h) and MMP was determined by flow cytometry. M1 gates show the percentage MMP loss. Data 
are expressed as the means ± SD of two independent experiments (n=4). *p<0.05; 
**p<0.01;***p<0.001. (B) Representative images of HepG2 cells showing loss of MMP under a 
fluorescence microscope (40X). Upper panel: cells were treated with DMSO 0.1 % (Control), linalool 
1.5 mM at different time points (0-48 h) or pre-incubated with the ROS scavenger NAC (5 mM) 2 h 
prior to the addition of linalool 1.5 mM. Lower panel: cells were treated for 24 h with DMSO 0.1 % 
(Control), linalool at different concentrations (1.0 – 2.0 mM) or rotenone 5 µM (12 h, positive 
control).  
 
3.7. Linalool induced MAPKs activation  
Based on the finding that linalool affected Ras expression and promoted ROS 
accumulation, the three stress-activated MAPK kinases (ERK, JNK, p38) were analyzed. 
HepG2 cells were treated with linalool 1.0, 1.5 and 2.0 mM for 24 h and protein expression 
and phosphorylation were evaluated by Western Blot (Fig.7A). Linalool significantly 
induced the phosphorylation of the three MAPKs starting from 1.5 mM whereas total 
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protein levels remained unchanged in response to linalool treatments. ERK, JNK and p38 
phosphorylation increased 39 and 42%, 38 and 49%, and 265 and 308% after treated with 
linalool 1.5 and 2.0 mM respectively (p<0.05 in all cases). To determine whether ROS 
production was responsible for MAPKs activation, HepG2 cells were treated with linalool 
1.5 mM for 24 h in absence or presence of 5 mM NAC (added 2 h before). As shown in 
Fig. 7B, NAC was able to at least partially prevent JNK and ERK phosphorylation (p<0.05), 
whereas no significant changes were observed for p38 phosphorylation.  
In contrary to its pro-survival function, sustained ERK activation is able to induce cell death 
under some circumstances [12]. In order to explore the role of ERK activation in linalool-
exposed HepG2 cells, ERK phosphorylation inhibitor (U0126, 10 µM) was added to the 
culture medium 2h before the addition of linalool (1.0-2.0 mM) for additional 24 h. As 
expected, cell viability was reduced in HepG2 cells cultured with 10 µM U0126 alone, 
whereas in combined treatments with linalool 1.5 and 2.0 mM (concentrations where ERK 
activity is increased), ERK inhibition induced a further strong decrease in cell viability to 33 
and 8%, respectively, suggesting a pro-survival role for ERK activation in this context (Fig. 
7C).  
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Fig. 7. Effect of linalool on MAPKs phosphorylation. (A) Representative Western blot analysis 
showing the dose-dependent effects of linalool on ERK, JNK and p38 phosphorylation in HepG2 
cells. Each phospho-kinase was normalized to its total kinase. (B) ERK, JNK and p38 expression in 
HepG2 cells treated with linalool 1.5 mM for 24 h in the absence or presence of NAC 5mM (added 2 
h before). Data are expressed as relative change compared to the control group, arbitrarily set at 1 
and expressed as the mean of three independent experiments. (C) HepG2 cells were pretreated for 
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2 h with ERK phosphorylation inhibitor (U0126, 10 µM) before the addition of linalool (1.0-2.0 mM) 
for additional 24 h. Cell viability was assessed by WST-1 expression. Data are presented as mean 
± SD (n=8). (a) p<0.001; (b) p<0.00001; (c) p<0.000001.  
 
3.8. Linalool modulates Akt/mTOR pathway 
The PI3K/Akt/mTOR represents the major pro-survival anti-apoptotic signaling pathway 
which promotes chemoresistance of cancer cells against several antineoplasic agents 
[28]. For this reason, we analyzed the expression of Akt and p70S6K (a surrogate marker 
for mTOR activation) in response to linalool exposure for 24 h.  
Linalool 1.0 and 1.5 mM inhibited Akt phosphorylation by a 55 and 45%, respectively 
(p<0.05), whereas at 2.0 mM, Akt phosphorylation returned to almost control values 
(p<0.05). On the other hand, a significant 80% reduction in p70S6K phosphorylation was 
observed at 2.0 mM (p<0.05) (Fig. 8A,C). Interestingly, a dose-dependent decrease in the 
total levels of Akt and p70S6K starting from 1.5 mM and 1.0 mM, respectively (Fig. 8B, 
p<0.05), was found. To shed light in Akt phosphorylation recovery at 2.0 mM, HepG2 cells 
were pre-incubated with Akt phosphorylation inhibitor Ly294002 (Ly, 20 µM) before 
addition of linalool for another 24 h. In this context, Ly alone reduced cell viability about 
29.5% (p<0.05) while in linalool treatment, cell viability was profoundly reduced from 
55.3% (linalool alone) to 12.3% (linalool + Ly) (Fig. 8D), suggesting that Akt 
phosphorylation recovery at linalool 2.0 mM could act as a pro-survival responsive 
mechanism. 
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Fig. 8. Effects of linalool on Akt and p70S6 kinases expression. (A) Representative Western 
blot analysis showing the dose-dependent effects of linalool on Akt and p70S6K in HepG2 cells. 
Each phospho-kinase was normalized to its total kinase. (B) Immunoblot bands corresponding to 
total Akt and p70S6K were quantified by densitometric analysis and then normalized to their 
respective β-actin. Data are expressed as relative change compared to the control group, arbitrarily 
set at 1 and expressed as the mean ± SD of three independent experiments. *p<0.05; 
**p<0.01;***p<0.001. (C) Immunoblot bands corresponding to p-Akt and p-p70S6K were quantified 
by densitometric analysis and then normalized to their respective β-actin. Data are expressed as 
relative change compared to the control group, arbitrarily set at 1 and expressed as the mean ± SD 
of three independent experiments. *p<0.05; **p<0.01;***p<0.001. (D) HepG2 cells were pretreated 
for 2 h with Akt phosphorylation inhibitor (Ly294002, 20 µM) before the addition of linalool 2.0 mM 
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for additional 24 h. Cell viability was assessed by WST-1 expression. Data are presented as mean 
± SD (n=8). (a) p<0.0001; (b) p<0.000001.   
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4. Discussion 
Linalool has been investigated as a promising chemopreventive and chemotherapeutic 
agent in several in vitro and in vivo models including liver [25], lung [25], prostate [19], 
leukemia [20], cervical [21], breast [22], human cancer cells and in tumor-bearing mice 
[23]. It has been evaluated as a mono-drug agent or combined with conventional drugs, 
and it was found that antiproliferative concentrations were strongly dependent on cell line 
in the micro- [19-22] or milimolar [23-25] range. However, the mechanisms by which 
linalool exerts its antiproliferative effects in HCC cells are not completely understood. 
Several monoterpenes including linalool were reported to act as antiproliferative agents 
against cancer cells by inducing cell growth arrest, both at G0/G1 [21,29] or G2/M 
[22,30]. In our study, linalool promoted a time and dose-dependent inhibition of cell 
growth, as indicated by the WST-1 assay. Moreover, particularly at 24 and 48 h, linalool 
significantly inhibited BrdU incorporation at concentrations lower that those needed for cell 
viability inhibition, thus demonstrating that linalool was able to specifically inhibit DNA 
synthesis acting as a cytostatic agent. In addition, we found that linalool promoted a 
G0/G1 phase cell cycle arrest in HepG2 cells followed by a strong decrease of the cell 
population in S phase. Although several studies mentioned above focused on linalool 
activity on cell cycle progression, only a few ones investigated its effect on cell cycle 
protein modulators [21]. Here we show that linalool modulates the expression of several 
cell cycle proteins. A marked reduction in Cdk-4 levels was found along with a slight but 
significant decrease in cyclin E, both of them are crucial for the progression in G1 and 
transition to S phase [31]. In addition, these changes were accompanied by a strong 
reduction in cyclin A levels, whose expression peaks in S phase and is dependent on G1/S 
transition [32], whereas the expression of the p21 and p27 inhibitors, key proteins 
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inhibiting cell cycle progression to S phase, were increased upon linalool treatments. All 
these findings are consistent with linalool-induced G0/G1 arrest and DNA synthesis 
inhibition, ratifying its role as one of the mechanisms by which this monoterpene inhibits 
HepG2 cell proliferation. The p53 levels, a tumor suppressor protein involved in cell cycle 
arrest and/or apoptosis in response to cellular stress, significantly decreased after linalool 
1.5 and 2.0 mM exposure, therefore suggesting that linalool acts through p53-independent 
antiproliferative mechanisms. Downregulation of p53 could be attributable to ERK 
activation, which in HepG2 cells is able to promote p53 degradation via Mdm2-dependent 
ubiquitination [33]. 
Linalool was reported to induce apoptosis in several cancer cell lines [19-21,23]. In this 
study, we show by three different and specific methodologies that linalool induced 
apoptosis. However, it seemed to contribute to a lesser extent to reduced cell growth than 
cell cycle arrest, since a moderate caspase-3 activation and an increased proportion of 
apoptotic cells were only observed at higher concentrations and longer exposure time to 
linalool.  
Ras GTPase is considered a therapeutic target in HCC, given that its downregulation 
leads to the inhibition of HCC cell growth through cell cycle arrest and/or apoptosis 
[34,35]. In a previous report [25] we have demonstrated that linalool was able to inhibit 
HepG2 and A549 cell viability, suggesting that the inhibition of the mevalonate pathway at 
the level of Ras prenylation, could be one of the antiproliferative mechanisms exerted by 
linalool, as it was reported for other monoterpenes [6]. Moreover, specific Ras inhibitors 
containing a 15 carbon isoprene moiety are able to inhibit Ras activity by competing for 
Ras docking sites at the cell membrane [34]. In the present work, Ras membrane levels 
were profoundly reduced in response to linalool.  
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ROS play a complex role in cancer biology. Whereas low levels of ROS normally stimulate 
cell proliferation, excessive ROS promote irreparable cell damage leading to cell death 
[36,37]. In fact, ROS appear as one of the most relevant mediators in cell cycle arrest and 
apoptosis exerted by antineoplasic drugs, including plant-derived natural compounds. 
Lewinska and collaborators [37] reported that increasing oxidative stress turned from 
cytostatic autophagy to cytotoxic autophagy leading to apoptosis in breast cancer cells 
exposed to the flavonoid diosmin. Linalool was shown to promote ROS generation in in 
vivo and in vitro cancer models [23]. In the current study, linalool significantly induced a 
dose-dependent increase in ROS generation from 1.5 mM onwards, which was involved in 
its antiproliferative activity since pre-incubation with NAC substantially prevented HepG2 
cell viability loss. The mechanisms by which linalool promotes ROS generation remain 
unclear, therefore we analyzed whether NADPH oxidase, a major source of cytoplasmic 
ROS, was implicated. Apocynin, a specific NADPH oxidase inhibitor, was unable to 
prevent either ROS generation or cell growth inhibition induced by linalool, suggesting that 
a mechanism other than NADPH oxidase activity is involved. These results are in line with 
previous reports proposing that linalool could be able to decrease SOD activity [38] and 
inhibit mitochondrial complexes I and II [39], subsequently promoting mitochondrial ROS 
production.  
Excessive ROS generation may lead to mitochondria membrane depolarization and, in 
turn, trigger the apoptotic intrinsic pathway [40]. In our system, linalool induced a mild 
MMP depolarization after 48 h treatments. The loss of MMP was prevented in the 
presence of the antioxidant NAC, suggesting that ROS generation promotes and/or 
exacerbates MMP loss and is probably involved in linalool-induced apoptosis. 
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Once activated in response to different cellular stimuli, ERK signaling is usually associated 
with cell survival while JNK and p38 act as tumor suppressors under stress conditions, 
activating many cellular events like cell cycle arrest, apoptosis and/or autophagy [11,41].  
ROS are able to activate the MAPK kinases by different mechanisms, among them 
through Ras activation, MAPK kinases (MAPKK) activation or MAPK phosphatases 
inactivation [12,40]. Linalool promoted a strong activation of the three MAPK starting from 
1.5 mM, which correlates with the significant increase in ROS generation. Antioxidant NAC 
totally prevented linalool-induced JNK phosphorylation, pointing to ROS as the source of 
JNK activation. Moreover, JNK has been identified as a direct promotor of the 
mitochondrial apoptotic pathway therefore suggesting that ROS-dependent JNK activation 
is involved in linalool-induced apoptosis, in addition to MMP loss, caspase-3 activation and 
PARP cleavage. On the other hand, NAC only partially prevented linalool-promoted ERK 
phosphorylation and had almost no effect on p38 activation. Therefore, it seems that other 
cellular mechanism than ROS are involved in ERK and p38 induction. In fact, Choi and 
colleagues [42] reported that ER stress promoted ERK and p38 activation, both involved 
in autophagy-enhanced cell survival. Indeed, HepG2 cell viability was not completely 
restored in the presence of NAC suggesting that ROS-independent mechanisms, like p38 
induction, Ras downregulation and/or Akt inhibition, could also be involved in linalool-
induced cell growth inhibition.  
In a context of a cellular stress, ERK activation is often associated with pro-survival 
functions, however depending on cell type, strength and duration of the signal, its 
sustained over-activation could promote cell death [12]. In our conditions, ERK activation 
seems to play a protective role against damage induced by linalool since ERK inhibition 
mediated by U0126 strongly increased HepG2 cell death. These findings are in line with 
those reported elsewhere which propose a cytostatic pro-survival autophagy induced by 
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ERK in response to oxidative injury in cancer cells, which turned into exacerbated cell 
death after ERK inhibition [36,42]. Moreover, ERK-mediated p53 downregulation 
presumably could favor HepG2 cells resistance to linalool-induced apoptosis. 
Is it well known that Akt positively regulates cell cycle progression by several mechanisms, 
among them, by inhibiting p27 expression and promoting the mTOR/p70S6K axis [43,44]. 
In the present study, linalool promoted a deep decrease in Akt phosphorylation at 1.0 and 
1.5 mM which paralleled p27 upregulation and G0/G1 arrest. On the other hand, the 
gradually increase in Akt phosphorylation beyond control levels for linalool 2.0 mM 
occurred in parallel with increased ROS generation and p70S6K inhibition. Akt kinase 
could be activated is response to excessive ROS production as a consequence of direct 
Ras activation, PI3K activation and/or a PI3K phosphatase (PTEN) inhibition [40]. mTOR 
inhibition also triggers Akt activation through a pro-survival negative feedback mechanism 
[28]. It seems that low concentrations of linalool reduced Akt phosphorylation through 
lowering Ras and/or PI3K activities, whereas at higher concentrations, linalool induced Akt 
phosphorylation most likely as a result of ROS generation and/or mTOR inhibition. Indeed, 
the presence of the specific PI3K/Akt inhibitor Ly294202 co-incubated with linalool 2.0 mM 
strongly exacerbated cell death, as it was observed in other cell models combining 
Ly294002 with the specific mTOR inhibitor rapamycin [28]. Altogether, these results 
illustrate the relevance of the Akt/mTOR pathway in HepG2 cell cycle arrest induced by 
linalool and support the pro-survival role of Akt phosphorylation recovery. The 
circumstance that p-p70S6K remained unaltered at linalool 1.0 and 1.5 mM despite Akt 
inhibition may be due to other kinases activity, such as ERK and/or AMPK, which are able 
to phosphorylate and modulate mTOR [45]. Interestingly, both Akt and p70S6K protein 
levels were substantially downregulated after linalool treatment, suggesting that linalool 
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inhibits Akt/mTOR/p70S6K pathway by mechanisms other than modulating their 
phosphorylation, which finally contribute to its antiproliferative activity.  
Based on the findings of this work, we propose a model for the mechanisms of action of 
linalool summarized in Fig. 9. 
 
Fig. 9. Proposed model for mechanisms of action involved in linalool-induced HepG2 growth 
inhibition. Linalool promotes G0/G1 cell cycle arrest from 1.0 mM through Ras and Akt inhibition 
leading to p27 upregulation, Cdk4 and cyclin A downregulation, as well as by increasing p21 levels 
(blue proteins). From 1.5 mM it also induces ROS generation which increase at 2.0 mM, promoting 
Ras, MAPKs activation, MMP depolarization and finally apoptosis through caspase-3 activation and 
PARP cleavage (orange proteins). In response to cellular stress, ERK and Akt are activated 
displaying anti-apoptotic/pro-survival roles since their inhibition result in HepG2 cell viability loss. 
Besides, linalool 2.0 mM also inhibits mTOR/p70S6K which contributes to G0/G1 arrest. 
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5. Conclusions 
Our results demonstrate that linalool inhibits hepatocellular carcinoma HepG2 cells 
through G0/G1 cell cycle arrest and apoptosis induction. ROS likely play a key role in 
linalool-induced cytotoxicity in HepG2 cells, which relies on the magnitude and the extent 
of exposure. For lower concentrations, linalool mainly acts as a cytostatic compound 
through Akt inhibition, promoting DNA synthesis inhibition by increasing p21 and p27 
inhibitors and decreasing Cdk4 and cyclin A proteins. At higher concentrations and a 
longer exposure time, it also exerts pro-apoptotic activities involving ROS production, 
MMP depolarization, caspase-3 activation and PARP cleavage. Co-treatment with specific 
ERK and Akt phosphorylation inhibitors increased linalool-induced HepG2 cell death 
suggesting protective functions of these kinases in response to cellular stress, thus 
explaining the observed moderate pro-apoptotic activity of linalool and pointing to both 
kinases as potential targets for linalool-combination HCC therapies. This work disclosed 
novel mechanisms involved in the antiproliferative activity of linalool against HepG2 cells 
and supports the fact that this naturally occurring isoprenoid should be considered as a 
potential safer chemotherapeutic agent in HCC therapy, employed alone and/or in 
combination with other chemotherapeutic agents (i.e. ERK inhibitors).  
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Figure Legends 
Fig. 1. Linalool inhibited HepG2 cell viability and proliferation. Cells were plated in 96-wells 
plates and incubated with various concentrations of linalool (0-2.5 mM) for 24, 48 and 72 h. (A) Cell 
viability assessed by WST-1 expression showing a dose- and time-dependent decrease in HepG2 
cell viability. (B) BrdU incorporation into DNA showing a dose-dependent inhibition of HepG2 cell 
proliferation exerted by linalool. Data are presented as the mean ± SD (n=8). *p<0.05; 
**p<0.01;***p<0.001. 
 
Fig. 2. Linalool induced G0/G1 cell cycle arrest. (A-B) Cell cycle distribution in HepG2 cells after 
exposed to linalool for 24 h (A) and 48 h (B). Data are expressed as mean ± SD (n=4). (C) HepG2 
cells were incubated with increasing concentrations of linalool for 24 h. Representative immunoblots 
of cyclin A, cyclin D1, cyclin E, Cdk2, Cdk4, p21, p27, p53 and β-actin (loading control). (D) 
Quantification of protein levels by densitometric analysis (n=4). Data are expressed as the mean ± 
SD. *p<0.05; **p<0.01;***p<0.001. 
 
Fig. 3. Linalool induced apoptosis in HepG2 cells. HepG2 cells were treated with linalool (1.0, 
1.5 and 2.0 mM) for 24 and 48 h and apoptosis was determined by different methodologies. (A) 
Caspase-3 activity was determined colorimetrically and the results were normalize to control cells 
(AU= arbitrary units, n=4). Data are presented as the mean ± SD; *p<0.05; **p<0.01;***p<0.001. (B) 
Representative fluorescence micrographs of apoptotic cells labeled by TUNEL assay after 48 h 
treatments with DMSO 0.1 % (Control) or linalool (LN) at the mentioned concentrations. Cells were 
examined under an Olympus BX51 fluorescence microscope (magnification × 10). Upper panel, 
nuclei stained with DAPI; lower panel, red-stained TUNEL positive cells. (C) Quantification of 
TUNEL positive cells. About 10-15 fields (100-200 cells/field) of three independent experiments 
were evaluated. Data are expressed as the mean ± SD. *p<0.05; **p<0.01;***p<0.001. (D) 
Representative immunoblot showing the poly ADP ribose polymerase (PARP) cleavage (apoptotic 
marker) after 48 h treatment (n=4).  
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Fig. 4. Effect of linalool on Ras expression. HepG2 cells were treated with linalool (1.0, 1.5 and 
2.0 mM) for 24 and 48 h. (A-B) Representative Western Blots of Ras protein in the membrane 
(mem-Ras) and cytosolic (cyt-Ras) fractions and total Ras after 24 h (A) and 48 h (B) treatments. 
(C-D) The resulting bands for 24 h (C) and 48 h (D) treatments were quantified by densitometric 
analysis and then normalized to their respective β-actin. Data are expressed as relative change 
compared to the control group, arbitrarily set at 1 and expressed as the mean ± SD of two 
independent experiments performed by quadruplicate. *p<0.05; **p<0.01;***p<0.001. 
 
Fig. 5. Oxidative stress induced by linalool. (A-B) HepG2 cells were treated with DMSO 0.1 % 
(Control), linalool (LN, 1.0, 1.5 and 2.0 mM) or pretreated with NAC 5 mM 2 h prior to addition of 
linalool 1.5 mM (LN 1.5 mM + NAC) for 3h, and then stained with 10 μM DCFH-DA for 30 min. (A) 
ROS production was evaluated by flow cytometry (upper panel). Representative images of HepG2 
cells showing ROS positive cells under a fluorescence microscope (20X, lower panel). (B) The 
fluorescence intensity of the cells analyzed by flow cytometry was calculated relative to that of 
control (set at 1). Data are expressed as the means ± SD of three independent experiments (n=4). 
*p<0.05; **p<0.01;***p<0.001. (C) HepG2 cells were treated with DMSO 0.1 % (Control), LPS (1 
µg/ml) or pretreated with apocynin (Apo, 250 µM) 2 h prior to addition of LPS (LPS + Apo) or LN 1.5 
mM (LN + Apo), and intracellular ROS were detected under a fluorescence microscope (20X). (D) 
HepG2 cells were pre-incubated with the ROS scavenger NAC (5 mM) or apocynin (250µM) 2 h 
prior to the addition of linalool (1.0 – 2.0 mM) for 24, 48 and 72 h. Cell viability was assessed by 
WST-1 expression. Data are presented as mean ± SD (n=8). *p<0.05; **p<0.01;***p<0.001. 
 
Fig. 6. Effect of linalool on mitochondrial membrane potential (MMP) in HepG2 cells. (A) 
HepG2 cells were treated with DMSO 0.1 % (Control) or linalool 1.5 mM at different time points (0-
48 h) and MMP was determined by flow cytometry. M1 gates show the percentage MMP loss. Data 
are expressed as the means ± SD of two independent experiments (n=4). *p<0.05; 
**p<0.01;***p<0.001. (B) Representative images of HepG2 cells showing loss of MMP under a 
fluorescence microscope (40X). Upper panel: cells were treated with DMSO 0.1 % (Control), linalool 
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1.5 mM at different time points (0-48 h) or pre-incubated with the ROS scavenger NAC (5 mM) 2 h 
prior to the addition of linalool 1.5 mM. Lower panel: cells were treated for 24 h with DMSO 0.1 % 
(Control), linalool at different concentrations (1.0 – 2.0 mM) or rotenone 5 µM (12 h, positive 
control).  
 
Fig. 7. Effect of linalool on MAPKs phosphorylation. (A) Representative Western blot analysis 
showing the dose-dependent effects of linalool on ERK, JNK and p38 phosphorylation in HepG2 
cells. Each phospho-kinase was normalized to its total kinase. (B) ERK, JNK and p38 expression in 
HepG2 cells treated with linalool 1.5 mM for 24 h in the absence or presence of NAC 5mM (added 2 
h before). Data are expressed as relative change compared to the control group, arbitrarily set at 1 
and expressed as the mean of three independent experiments. (C) HepG2 cells were pretreated for 
2 h with ERK phosphorylation inhibitor (U0126, 10 µM) before the addition of linalool (1.0-2.0 mM) 
for additional 24 h. Cell viability was assessed by WST-1 expression. Data are presented as mean 
± SD (n=8). (a) p<0.001; (b) p<0.00001; (c) p<0.000001.  
 
Fig. 8. Effects of linalool on Akt and p70S6 kinases expression. (A) Representative Western 
blot analysis showing the dose-dependent effects of linalool on Akt and p70S6K in HepG2 cells. 
Each phospho-kinase was normalized to its total kinase. (B) Immunoblot bands corresponding to 
total Akt and p70S6K were quantified by densitometric analysis and then normalized to their 
respective β-actin. Data are expressed as relative change compared to the control group, arbitrarily 
set at 1 and expressed as the mean ± SD of three independent experiments. *p<0.05; 
**p<0.01;***p<0.001. (C) Immunoblot bands corresponding to p-Akt and p-p70S6K were quantified 
by densitometric analysis and then normalized to their respective β-actin. Data are expressed as 
relative change compared to the control group, arbitrarily set at 1 and expressed as the mean ± SD 
of three independent experiments. *p<0.05; **p<0.01;***p<0.001. (D) HepG2 cells were pretreated 
for 2 h with Akt phosphorylation inhibitor (Ly294002, 20 µM) before the addition of linalool 2.0 mM 
for additional 24 h. Cell viability was assessed by WST-1 expression. Data are presented as mean 
± SD (n=8). (a) p<0.0001; (b) p<0.000001.  
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Fig. 9. Proposed model for mechanisms of action involved in linalool-induced HepG2 growth 
inhibition. Linalool promotes G0/G1 cell cycle arrest from 1.0 mM through Ras and Akt inhibition 
(blue proteins) leading to p27 upregulation, Cdk4 and cyclin A downregulation. From 1.5 mM it also 
induces ROS generation which increase at 2.0 mM, promoting Ras, MAPKs activation, MMP 
depolarization and finally apoptosis through caspase-3 activation and PARP cleavage (orange 
proteins). In response to cellular stress, ERK and Akt are activated displaying anti-apoptotic/pro-
survival roles since their inhibition result in HepG2 cell viability loss. Besides, linalool 2.0 mM also 
inhibits mTOR/p70S6K which contributes to G0/G1 arrest. 
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